Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-25-008326
Filing Date
2025-10-02
Accepted
2025-10-02 16:56:12
Documents
1
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 3844
  Complete submission text file 0001225208-25-008326.txt   5341
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Issuer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address PFIZER INC. ATTN CORPORATE SECRETARY 66 HUDSON BLVD. E. NEW YORK NY 10001
Business Address
SMITH JAMES C (Reporting) CIK: 0001611777 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-03619 | Film No.: 251370276